Attached files
file | filename |
---|---|
10-K - AMERICAN ORIENTAL BIOENGINEERING, INC. - AMERICAN ORIENTAL BIOENGINEERING INC | aob_10k-123109.htm |
EX-23.3 - CONSENT - AMERICAN ORIENTAL BIOENGINEERING INC | aob_10k-ex2302.htm |
EX-31.2 - CERTIFICATION - AMERICAN ORIENTAL BIOENGINEERING INC | aob_10k-ex3102.htm |
EX-23.1 - CONSENT - AMERICAN ORIENTAL BIOENGINEERING INC | aob_10k-ex2301.htm |
EX-31.1 - CERTIFICATION - AMERICAN ORIENTAL BIOENGINEERING INC | aob_10k-ex3101.htm |
Exhibit
32
Certification
Pursuant
to 18 U.S.C. Section 1350,
As
Adopted
Pursuant
to Section 906 of the
Sarbanes
- Oxley Act of 2002
In
connection with the Annual Report of American Oriental Bioengineering, Inc. (the
“Company”), on Form 10-K for the year ended December 31, 2009 as filed with
the Securities and Exchange Commission (“SEC”) on the date hereof (the
“Report”), each of the undersigned , Tony Liu, Chief Executive
Officer of the Company and Yanchun Li, Chief Financial Officer of the Company,
certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:
|
(6)
|
the
Report fully complies, in all material respects, with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and
|
|
(7)
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
/s/
Tony Liu
Name: Tony
Liu
Title: Chief
Executive Officer
March
15, 2010
/s/
Yanchun Li
Name: Yanchun
Li
Title: Chief
Financial Officer
March
15, 2010
|
A signed
original of this written statement required by Section 906 of the Sarbanes
Oxley Act of 2002 has been provided to the Company and will be retained by the
Company and will be furnished to the SEC or its staff upon request. This exhibit
is not “filed” for purposes of Section 18 of the Securities Exchange Act of
1934 but is instead furnished as provided by applicable rules of the
SEC.